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Neuronal Nitric Oxide Synthase Activation by Vasoactive
Intestinal Peptide in Bovine Cerebral Arteries *Carmen Gonzalez, tCarla Barroso, *Carmen Martin, tSergio Gulbenkian, and *Carmen Estrada Summary: The partIcipation of nitric oxide and vasoactive intestinal peptide (VIP) in the neurogenic regulation of bovine cerebral arteries was investigated, Nitrergic nerve fibers and ganglion-like groups of neurons were revealed by NADPH diaphorase staining in the adventitial layer of bovine cerebral arteries, NADPH diaphorase also was present in endothelial cells but not in the smooth muscle layer. Double immunola beling for neuronal nitric oxide synthase and VIP indicated that both molecules co-localized in the same nerve fibers in these vessels. Transmural nerve stimulation (200 rnA, 0.2 millisec onds, I to 8 Hz) of endothelium-denuded bovine cerebral artery rings precontracted with prostaglandin F2ex, produced tetrodo toxin-sensitive relaxations that were completely suppressed by AP-nitro-L-arginine methyl ester (L-NAME) and by the gua nylyl cyclase inhibitor I H-[ I ,2.4Joxadiazolo[ 4,3-a]quinoxaline (ODQ), but were not affected by the adenylyl cyclase inhibitor 9-(tetrahydro-2-furanyl)-9H-purin-6-amine (SQ 22, 536) , nor by VIP tachyphylaxis induced by pretreatment with I fLmol/L Immunohistochemical and ultrastructural studies show that cerebral arteries are surrounded by a dense network of perivascular nerves, part of which contains vasodilator neuropeptides such as vasoactive intestinal peptide (VIP) VIP. Transmural nerve stimulation also elicited increases in intracellular cyclic GMP concentration, which were prevented by L-NAME, and small decreases in intracellular cyclic AMP concentration. Addition of VIP to bovine cerebral artery rings without endothelium produced a concentration-dependent re laxation that was partially inhibited by L-NAME, ODQ, and SQ 22,536. The effects of L-NAME and SQ 22,536 were additive. VIP induced a transient increase in intracellular cyclic GMP concentration, which was maximal I minute after VIP addition, when the highest relaxation rate was observed, and which was blocked by L-NAME. It is concluded that nitric oxide produced by perivascular neurons and nerve fibers fully accounts for the experimental neurogenic relaxation of bovine cerebral arteries and that VIP, which also is present in the same perivascular fibers, acts as a neuromodulator by activating neuronal nitric oxide synthase. Key Words: Cerebrovascular innervation Nitric oxide-NADPH diaphorase-Nitrergic nerves Perivascular nitrergic neurons-Vasodilator nerves. (Larsson et al., 1976; Suzuki et al., 1988) , substance P (Uddman et al., 198 1; Suzuki et al., 1989) , or calcitonin gene-related peptide (Suzuki et al., 1989) . In addition, functional studies reveal that cerebral arteries relax when perivascular nerves are electrically stimulated. This ef fect occurs in the presence of adrenergic and cholinergic receptor blockade (Lee et al., 1978; Toda, 198 1) and it is therefore considered to be a nonadrenergic noncholiner gic (NANC) neurogenic relaxation. It has been recently reported that the neurogenic relaxation of cerebral arter ies from several species is substantially reduced when nitric oxide (NO) synthesis is prevented by L-arginine analogues (Toda and Okamura, 1990; Gonzalez and Es trada, 199 1; Gaw et al., 199 1; Ayajiki et al., 1993) . The NO involved in neurogenic relaxation originates in peri vascular nerves containing nitric oxide synthase (NOS) and NADPH-diaphorase activity (Bredt et al., 1990; Es trada et al., 1993; Nozaki et al., 1993) .
Although NO currently is considered as a peripheral neurotransmitter involved in NANC relaxation in many organs (Ny et ai., 1995; Kim et ai., 1995; Takahashi et ai., 1995; Takahashi and Owyang, 1995) , a controversy exists as to whether neuropeptides, such as VIP or cal citonin gene-related peptide, also contribute to the neu rogenic relaxation, based on the existence of a relaxation component resistant to NOS inactivation in some tissues (Kim et ai., 1995; Ny et ai., 1995; Takahashi et ai., 1995; Takahashi and Owyang, 1995) . In fact, VIP, which co localizes with NOS in peripheral nerves from different territories (Ekblad et ai., 1994; Hayashida et ai., 1996; Takahashi et ai., 1995; Klimaschewski et ai., 1994; Bar roso et ai., 1996) , has been shown to contribute to NANC relaxation in some tissues, such as the rabbit corpus ca verno sum (Kim et ai., 1995) , the cat lung (Takahashi et ai., 1995) , or the rat stomach (Takahashi and Owyang, 1995) , but not in others, such as the cat esophagus (Ny et ai., 1995) or the human trachea (Ward et ai., 1995) . In cerebral blood vessels, VIP has been proposed as a func tional dilator neurotransmitter (Lee et aI., 1984; Bevan et ai., 1986; Gaw et ai., 199 1) , but conclusive experimental evidence has never been provided. Nitric oxide and VIP exert their relaxant effect on smooth muscle cells through two separate signal trans duction mechanisms. Activation of guanylyl cyclase by NO results in the accumulation of cyclic GMP (cGMP) (Schmidt et at, 1993) , whereas the interaction of VIP with specific membrane receptors leads to increases in cyclic AMP (cAMP) concentration on activation of ad enylyl cyclase (Huang and Rorstad, 1984; Suzuki et ai., 1985) .
In the current report, we analyze the participation of these two pathways in the relaxation produced by stimu lation of perivascular nerves in bovine cerebral arteries and their possible interaction. We show that neuronal NO fully accounts for the neurogenic relaxation and that VIP, which is present in the same nerve terminals, acts as a neuromodulator by regulating NO synthesis in the nitrer gic nerves.
METHODS
Bovine brains were obtained from a local slaughterhouse and transported to the laboratory in phosphate-buffered saline so lution (PBS) at 4°C. A first-order branch of the anterior cere bral artery was isolated for functional experiments and for bio chemical determinations. The endothelium was removed by gently introducing a cotton thread through the vascular lumen, taking care to preserve the adventitial layer.
Isometric tension recordings
Arterial rings, 4 mm in length, were suspended on two in traluminal parallel wires, introduced in an organ bath contain ing a physiologic solution (in mmollL: 115 N aCl, 4.6 KCI, 1.25 CaClz, 25 NaHC03, 1.2 KH2P04, 1.2 MgS04 ' 0.01 EDT A, and 11 glucose), and connected to a Piodem strain gauge for iso metric tension recording. All rings were equilibrated at a pas sive tension of 1 g for 90 minutes. Before starting the experi-J Cereb Blood Flow Metab, Vol. 17. No. 9, 1997 ments, rings were contracted with prostaglandin F2<Y and ace tylcholine (I to 10 j-LmollL) was added to confirm functionally the absence of endothelium. Only arteries that did not dilate in the presence of acetylcholine were used. Sodium nitroprusside (10 j-LmollL) was added at the end of each experiment, and the relaxation obtained was considered to be 100%. In experiments in which guanylyl cyclase was inhibited, the maximal relax ation was obtained with papaverine (100 j-LmollL) in both con trol and treated vessels.
Transmural nerve stimulation (TNS; 200 rnA, 0.2 millisec onds, I to S Hz) was applied to precontracted arterial rings using two parallel platinum electrodes, one at each side of the vessel, connected to a CS-20 stimulator (Cibertec, Madrid, Spain). The neurogenic nature of the stimuli was demonstrated, since TNS responses were blocked by tetrodotoxin (I to 10 j-LmollL). The interval between consecutive stimuli was at least S to 10 minutes. TNS always was performed in the presence of 5 j-LmollL indomethacin, I j-LmollL phentolamine, I j-LmollL propranolol, and 0.1 j-LmollL atropine to prevent any effect mediated by prostaglandins, noradrenaline, or acetylcholine. Two or three reproducible responses were obtained before
(ODQ, 10 j-LmollL), or 9-(tetrahydro-2-furanyl)-9H-purin-6-amine (SQ 22,536, 200 j-LmollL) were added to the organ bath, and the effect of TNS was recorded 20 minutes later. The VIP concentration curves were performed in a cumula tive manner in precontra:cted arteries. Only one curve was ob tained for each vascular ring to avoid tachyphylaxis. Experi ments in the presence and absence of L-NAME, ODQ, or SQ 22,536 were performed in pairs of vessels isolated from the same animal.
Cyclic GMP and cyclic AMP measurements
Arterial rings were mounted in the organ baths as for the functional experiments. The absence of relaxing responses to acetylcholine and the presence of TNS-induced relaxations were assessed in each segment. When L-NAME was added, TNS was applied 20 minutes later to confirm that NOS was inhibited. Arteries were contracted with prostaglandin F2<x and frozen with liquid nitrogen-embedded forceps without any fur ther drug (controls), 60, 105, and 240 seconds after addition of 10 nmollL VIP, and 12 and 40 seconds after initiation of TNS (S Hz, 12 seconds) in the absence and presence of L-NAME.
Frozen samples later were used for cGMP and cAMP determi nations by radioimmunoassay using a kit from New England Nuclear (DuPont, Boston, MA, U.S.A.).
Histochemistry
The entire circle of Willis and its major branches were dis sected out of the brain in the slaughterhouse, rinsed and per fused with PBS, and immediately introduced in fixative. The arteries used for NADPH-diaphorase staining were fixed for 2 hours in 4% paraformaldehyde in 0.1 mollL phosphate buffer, pH 7.4, at 4°C, and then washed with phosphate buffer and crioprotected by incubation for 1 hour with increasing concen trations of sucrose (5% to 20%, weight/volume) and overnight with 30% (weight/volume) sucrose. Longitudinal sections (40 j-Lm) were obtained with a freezing microtome, mounted on slides, and incubated for 70 minutes at 37°C in a mixture con taining 1 mmollL NADPH, 1 mmollL nitro blue tetrazolium, and 0.3% Triton-X-100, in 0.1 mollL phosphate buffer, pH S.O.
The sections were rinsed in phosphate buffer, dehydrated, and coverslips were fixed with Permount.
The vessels used for immunohistochemical study were fixed for 16 hours at 4°C in Zamboni's fixative (Steffanini et aI., 1967) and washed in PBS contammg 15% (weight/volume) sucrose and 0.01 % (weight/volume) sodium azide. After pre treatment with 0.2% (volume/volume) Triton X-IOO in PBS for 2 hours. and with Pontamine Sky blue (Cowen et a!., 1985) for 30 minutes, the arterial segments were incubated overnight at room temperature with a rabbit antibody against NOS (Ham mersmith HospitallWellcome, 1:400) and a guinea-pig anti body against VIP (Euro-Diagnostica, I :300) diluted in PBS.
Arteries then were washed in PBS and incubated with a mixture of tetramethylrhodamine isothiocyanate-conjugated mouse an tiserum against rabbit IgG (Sigma, I: 100) and fluorescein isothiocyanate-conjugated mouse antiserum against guinea-pig IgG (Sigma, 1 "
: 10) for I hour at room temperature. The arteries were mounted and examined under a microscope equipped for epiillumination with filters selective for fluorescein and rhoda mine fluorescence. In control experiments, no immunostaining was observed when primary antisera were omitted, replaced with nonimmune serum, or preadsorbed with their correspond ing antigens (0.1 to 1 [LmoIlL) for 24 hours at 4 DC. Labeled secondary antisera did not exhibit cross-reactivity with IgG from inappropriate species.
Statistical analysis
Data are expressed as arithmetic means plus/minus standard deviation, except for ECso values, which are presented as geo metric means with confidence limits. Statistical comparisons between groups were made using Student ' s t test for paired or unpaired samples, except for ECso values, which were analyzed by the nonparametric Wilcoxon test. P < 0.05 was considered to be statistically significant.
Chemicals
The following compounds were used: prostaglandin F2o< ' acetylcholine chloride, sodium nitroprusside. tetrodotoxin, in domethacin, phentolamine hydroc1oride, DL-propranolol, atro pine methyl bromide, Nw-nitro-L-arginine methyl ester, hemo globin (bovine), VIP (porcine), NADPH, and nitro blue tetra zolium, all of them purchased from Sigma Chemical Co. (St. Louis, MO, U.S.A.). SQ 22,536 was from Research Biochemi cals International (Natick, MA, U.S.A.), and ODQ was from Tocris (Bristol, U.K.). Stock solutions (10 to 30 mmollL) were made in water except for indomethacin, prostaglandin F2o<' and ODQ, which were dissolved in 5% NaHC03, ethanol, and di methyl sulfoxide, respectively. All subsequent dilutions were made in 0.9% NaCI.
RESULTS
Histochemical staining for NADPH-diaphorase activ ity in longitudinal sections of bovine pial arteries re vealed the presence of large bundles of positive-staining fibers running longitudinally in the adventitial layer (Fig.  IA) . These bundles branched off in different directions, leading to single varicose nerve fibers (Fig. 1 B) . In some areas, heavily stained neurons presenting clear nuclei and grouped in a ganglion-like manner were observed (Figs. lC and ID). NADPH-diaphorase staining also was pre sent in endothelial cells but not in the smooth muscle layer (Fig. IC) . Double immunolabeling for neuronal NOS and VIP in whole-mounted arterial segments showed a co-localization of both markers in the same perivascular nerve fibers (Figs. IE and IF) .
To determine the contribution of NO and VIP to the relaxation induced by depolarization of perivascular nerves, TNS was applied to endothelium-denuded pre contracted arterial rings before and after blockade of NOS, guanylyl cyclase, or adenylyl cyclase. TNS in duced a transient relaxation that was abolished by the NOS inhibitor L-NAME ( Figs. 2A and B) , but not by the inactive enantiomer D-NAME (Fig. 2A) . The effect of L-NAME was partially reversed by the simultaneous ad ministration of L-arginine ( Fig. 2A) . In the presence of the specific guanylyl cyclase inhibitor ODQ (Garthwaite et aI., 1995; Moro et aI., 1996) , arterial rings did not relax on TNS ( Figs. 2A and B) ; however, the neurogenic re sponse was not modified by the adenylyl cyclase inhibi tor SQ 22,536 (Fig. 2B) . Simultaneous application of L-NAME and SQ 22,536 produced the same effect as L-NAME alone (Fig. 2B ). In addition, TNS response was not altered when applied after 30 minutes' preincubation of the vessels in the presence of 1 /-LmollL VIP (Fig. 2B) , conditions in which VIP response was clearly diminished because of tachyphylaxis (Fig. 2C) . The intracellular concentrations of the cyclic nucleo tides cGMP and cAMP were measured before and during TNS-induced relaxation. In agreement with the func tional results described earlier, significant increases of cGMP concentration were elicited by TNS (Fig. 3A) , whereas a concomitant small decrease in cAMP concen tration was produced (Fig. 3B) . The TNS-induced incre ment in cGMP concentration was caused by guanylyl cyclase activation by NO because it was abolished in the presence of L-NAME (Fig. 3A) . Basal concentrations of cGMP in unstimulated endothelium-denuded arteries were significantly lower than those measured in intact vessels (60 ± 8 fmollmg protein, n = 15, versus 200 ± 40 fmol/mg protein, n = 8, respectively), and similar to those detected in intact vessels when NOS was inhibited by L-NAME (60 ± 15 fmol/mg protein, n = 4). In the absence of endothelium, L-NAME produced no further decrease in basal cGMP concentration (Fig. 3A) .
To analyze the signal transduction mechanisms of VIP action in bovine cerebral arteries, concentration response curves were obtained when the NO/cGMP pathway was blocked by either L-NAME or ODQ, when the cAMP pathway was inhibited by SQ 22,536, and when transduction through both pathways was prevented by simultaneous addition of L-NAME and SQ 22,536. Addition of VIP to arterial rings without endothelium produced a sustained concentration-dependent relaxation (Fig. 4) . The relaxation induced by low concentrations of the peptide was inhibited by L-NAME (Fig. 4A) , result ing in a significant increase in the ECso values without modification of the Emax (Table 1 ). In the presence of ODQ, a reduced response also was observed (Fig. 4B) , except at the highest concentration used. Analysis of the data revealed a small but significant increase in ECso values without modification of the Emax (Table 1) effect similar to that of L-NAME. SQ 22,536 also inhib ited VIP-induced relaxations in bovine cerebral arteries, although its effects were more evident at higher peptide concentrations (Fig. 4C ), leading to a significant de crease in the Emax values without modification of the EC50 (Table 1) . When both L-NAME and SQ 22,536 were added simultaneously, the relaxation produced by VIP was decreased throughout the whole range of the concentration-response curve, indicating that both ef fects were additive ( Fig. 4D and Table 1 ).
To assess further the participation of the NO-cGMP pathway in the relaxation induced by VIP in bovine ce rebral arteries, cGMP levels were measured at different times after addition of the peptide. Cyclic GMP in creased 1 minute after addition of VIP to the organ bath, J Cereb Blood Flow Metab, Vol. 17, No.9, 1997 remained elevated for 2 minutes, and returned to control levels 4 minutes after addition of the peptide (Fig. 5A) . In the presence of L-NAME, no increase in cGMP was observed on VIP administration (Fig. 5B) .
DISCUSSION
We investigated the involvement of NO and VIP in the regulation of bovine cerebral artery function by perivas cular nerves. Our results suggest that there is an interplay between these two messengers, which are contained in the same nerve population, with NO being the peripheral neurotransmitter directly relaxing smooth muscle cells and VIP acting as an autocrine neuromodulator.
The presence of perivascular nitrergic nerves, shown here by NADPH-diaphorase staining, used as a marker for NOS (Hope et a!., 199 1; Dawson et aI., 199 1) , and by NOS immunohistochemical study, is in agreement with previous results in the cerebral arteries of rats, cats, guinea-pigs, and humans (Barroso et aI., 1996; Bredt et aI., 1990 , Estrada et a!., 1993 , Nozaki et a!., 1993 . How ever, it is interesting to notice the detection in bovine vessels of stained neuronal cell bodies grouped in gan glion-like structures, with morphologic features similar to those previously described in cats (Estrada et aI., 1993; Lee, 1994) . Although nitrergic neurons in the sphenopalatine ganglion have been shown to project to cerebral arteries in the rat (Nozaki et a!., 1993; Minami et a!., 1994; Suzuki et a!., 1994) , the presence of intrinsic NOS neurons in the cerebral vessel wall in cats and cows suggests that some of the nitrergic nerves have a local origin, at least in these species. The coexistence of NOS and VIP demonstrated here for bovine cerebral arteries seems to be a common fea ture of NANC nerves in the peripheral nervous system. Partial or total co-localization of these two transmitters has been reported in different locations, including the gastrointestinal tract of several species (Ekblad et a!., 1994) , the canine corpus cavernosum (Hayashida et aI., 1996) , rat nasal mucosa (Takahashi et aI., 1995) , guinea pig heart (Klimaschewski et a!., 1994) , and cerebral blood vessels (Nozaki et aI., 1993; Barroso et a!., 1996) . This frequent co-localization of VIP and NOS in periph eral nerve terminals suggests a possible functional inter action between these two relaxing pathways.
Our results show that VIP-mediated activation of ad enylyl cyclase did not occur during neurogenic stimula tion of bovine cerebral blood vessels, because of the following: (I) there was no intracellular accumulation of cAMP, (2) the relaxation was not impaired by inhibition of adenylyl cyclase with SQ 22,536, and (3) VIP-induced tachyphylaxis did not modify the vascular relaxation to TNS. On the contrary, the guany1yl cyclase pathway must have been activated, since (1) significant increases in intracellular cGMP concentrations were detected dur ing TNS, and (2) the relaxing response to TNS was com pletely blocked by the adenylyl cyclase inhibitor ODQ. The disappearance of any significant relaxation or cGMP accumulation in the presence of the NOS inhibitor L NAME points to the conclusion that the NANC relax ation of bovine cerebral arteries was entirely caused by activation of the NO-cGMP pathway.
One interesting finding is that cGMP levels were low in endothelium-denuded arteries and that they were not further decreased by L-NAME. This indicates that there is no basal NO production in nitrergic terminals in un stimulated arteries. On the contrary, endothelial NOS is tonically activated, since, in resting conditions, arteries with intact endothelium presented higher cGMP concen trations, and these decreased to the levels measured in the absence of endothelium when treated with L-NAME. Although VIP does not behave as a neurotransmitter in bovine cerebral vessels, the possibility exists that it acts as a neuromodulator by modifying the release of the coexisting neurotransmitter, as is the case with other neu ropeptides. We show here that VIP causes relaxation of bovine cerebral arteries by two independent pathways. First, and in accordance with the well known interaction of VIP with adenylyl cyclase-coupled receptors (Huang and Rorstad, 1984; Suzuki et aI., 1985) , VIP relaxes the vessel by adenylyl cyclase activation, since the relax ation decreased in the presence of an inhibitor of this enzyme. Second, it activates the NO-cGMP pathway, as demonstrated by the increase in cGMP concentration and the partial inhibition of the VIP-induced relaxation by L-NAME and ODQ. The NO-cGMP pathway was pre dominant at low VIP concentrations, whereas the adeny-TABLE 1. EC S () and Emax values for VIP-induced relaxation in bovine cerebral arteries in the absence and presence of L-NAME, SQ 22,536 or both Control (7) L-NAME (7) Control (8) ODQ (8) Control (7) SQ 22.S36 (7) Control (S) SQ 22,S36 + L-NAME (S) I.S (0.02-6.1) 3.7 (0.8-11.9):j: 4.88 (-0.9-19.1) 10.3 (-7.3-47.1):j: 3.9 (2.2-6.9) 3.7 (1.8-11.6) 4.0 (2.4-6.4) 3.9 (-4.6--20. lyl cyclase inhibitor was more effective at high VIP con centrations. Furthermore, the cGMP increases induced by VIP were maximal I minute after addition of the peptide, the time at which the highest relaxation rate was reached, and returned to control levels 3 minutes later, when the vessel still was relaxed, indicating that the NO cGMP pathway is important in the initial stages of VIP induced relaxation. These findings suggest that in bovine cerebral arteries, VIP activates NOS by acting on recep tors that differ from those coupled to adenylyl cyclase in both the affinity and the time course of the signal trans duction. In relation to this possibility, it has recently been reported that, in dispersed gastric muscle cells, VIP in teracts with a newly defined class of specific receptors, not recognized by the peptide histidine-isoleucine, which induce a G protein-dependent influx of Ca 2 + and a subsequent activation of NOS (Murthy et aI., 1993) . Shortly before the identification of perivascular nitrer gic plexi in the cerebral vasculature, Gaw and others (199 1) described a decrease in the relaxation produced by VIP in sheep cerebral arteries on incubation with hemoglobin or the NOS inhibitor N° -monomethyl-L arginine, and concluded that the neurogenic vasodilation was largely mediated by VIP through a direct action on smooth muscle by a mechanism involving synthesis of NO. However, it is unlikely that endogenous VIP released by TNS acts on NOS-related smooth muscle re ceptors, because an interaction with smooth muscle cells also would result in a concomitant participation of the cAMP-mediated pathway. Moreover, in contrast to what happens in the gastrointestinal smooth muscle, where a new isoform of Ca 2 + /calmoduline-dependent membrane bound NOS has been described (Berezin et aI., 1994; Murthy and Makhlouf, 1994) , this enzyme is not present in cerebral artery smooth muscle cells, as demonstrated by the absence of NADPH-diaphorase staining both in arterial sections (current results) and in isolated smooth muscle cells derived from bovine cerebral arteries and maintained in culture (Estrada et aI., 1995) . The removal of the endothelial layer and the absence of NADPH di aphorase in the smooth muscle cells in our arterial seg ments point to the perivascular nitrergic fibers and neu rons as the only source of NOS in these vessels. Because of the co-localization of NOS and VIP, we propose that this neuropeptide acts as a neuromodulator, increasing the synthesis and release of the coexisting neurotrans mitter NO by acting on regulatory autoreceptors coupled to NOS activation.
